Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+) metastatic breast cancer. The research-use-only assay, which includes a qPCR detection kit and an isolation kit for cell-free DNA and exosomal RNA, will also be featured at the ongoing San Antonio Breast Cancer Symposium. The latest development is expected to bolster the company's Diagnostics and Spatial Biology segment. Since the announcement on Dec. 10, Bio-Techne's shares dipped 0.4%, closing at $76.81 in yesterday's session. On a promising note, Bio-Techne's deep expertise in developing highly sensitive, qPCR-based assays with capabilities in extracting data from exosomes makes it uniquely positioned to provide a high-quality, streamlined and multiplexed ESR1 mutation assay for broad use in clinical research laboratories. Accordingly, we expect the latest development to boost the market sentiment toward TECH stock. Bio-Techne has a market capitalization of $12.25 billion. The Zacks Consensus Estima
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEPR Newswire
- BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT [Yahoo! Finance]Yahoo! Finance
- BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENTPR Newswire
- ScaleReady awards a G-Rex® Grant to Moonlight Bio [Yahoo! Finance]Yahoo! Finance
- ScaleReady awards a G-Rex® Grant to Moonlight BioPR Newswire
TECH
Earnings
- 10/30/24 - Beat
TECH
Sec Filings
- 11/14/24 - Form SC
- 11/8/24 - Form SC
- 11/5/24 - Form 4
- TECH's page on the SEC website